Angelo G. Scopelianos Ph.D.
Net Worth
Last updated:
What is Angelo G. Scopelianos Ph.D. net worth?
The estimated net worth of Mr. Angelo G. Scopelianos Ph.D. is at least $3,572,473 as of 16 Mar 2023. He owns shares worth $84,925 as insider, has earned $10,098 from insider trading and has received compensation worth at least $3,477,450 in AxoGen, Inc..
What is the salary of Angelo G. Scopelianos Ph.D.?
Mr. Angelo G. Scopelianos Ph.D. salary is $695,490 per year as Chief R&D Officer in AxoGen, Inc..
How old is Angelo G. Scopelianos Ph.D.?
Mr. Angelo G. Scopelianos Ph.D. is 70 years old, born in 1955.
What stocks does Angelo G. Scopelianos Ph.D. currently own?
As insider, Mr. Angelo G. Scopelianos Ph.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
AxoGen, Inc. (AXGN) | Chief R&D Officer | 5,529 | $15.36 | $84,925 |
What does AxoGen, Inc. do?
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Angelo G. Scopelianos Ph.D. insider trading
AxoGen, Inc.
Mr. Angelo G. Scopelianos Ph.D. has made only one insider trade between 2020-2023, according to the Form 4 filled with the SEC.
As of 16 Mar 2023 he still owns at least 5,529 units of AXGN stock.
AxoGen key executives
AxoGen, Inc. executives and other stock owners filed with the SEC:
- Mr. Angelo G. Scopelianos Ph.D. (70) Chief R&D Officer
- Mr. Bradley L. Ottinger J.D. (55) Gen. Counsel & Chief Compliance Officer
- Mr. Eric A. Sandberg (60) Chief Commercial Officer
- Mr. Peter J. Mariani (61) Executive Vice President & Chief Financial Officer
- Ms. Karen Zaderej (63) Chairman, Pres & Chief Executive Officer